{{Rsnum
|rsid=2126986
|Gene=GNAO1
|Chromosome=16
|position=56317795
|Orientation=minus
|GMAF=0.4183
|Gene_s=GNAO1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 23.9 | 48.7 | 27.4
| HCB | 12.4 | 33.6 | 54.0
| JPT | 4.4 | 38.9 | 56.6
| YRI | 42.2 | 48.3 | 9.5
| ASW | 35.1 | 50.9 | 14.0
| CHB | 12.4 | 33.6 | 54.0
| CHD | 4.6 | 33.3 | 62.0
| GIH | 29.7 | 48.5 | 21.8
| LWK | 28.2 | 54.5 | 17.3
| MEX | 24.1 | 31.0 | 44.8
| MKK | 37.2 | 46.8 | 16.0
| TSI | 11.8 | 57.8 | 30.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=24549219
|Title=Comprehensive pathway-based analysis identifies associations of BCL2, GNAO1 and CHD2 with non-obstructive azoospermia risk
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}